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Abstract 
Study Objectives: Atrial fibrillation (AF) is the most prevalent arrhythmia and is associated with a five-
fold increase in stroke risk. Many individuals with AF go undetected and thus untreated. These 
individuals are often asymptomatic or have paroxysmal AF. There are ongoing debates on whether mass 
screening for AF in the general population is to be recommended. However, there is incentive in 
performing systematic screening for specific at risk groups such as individuals suspected of sleep-
disordered breathing where an important association between AF and obstructive sleep apnea (OSA) has 
been demonstrated. In this research we introduce a new methodology leveraging digital biomarkers and 
recent advances in artificial intelligence (AI) for the purpose of mass AF diagnosis from hours of single 
channel electrocardiogram (ECG) recording. We demonstrate the value of such methodology in a large 
population sample at risk of sleep disordered breathing. 
 
Methods: Four databases, totaling n=3,088 patients and p=26,913 hours of continuous single channel 
electrocardiogram raw data were used. Three of the databases (n=125, p=2,513) were used for training a 
machine learning model in recognizing AF events from beat-to-beat interval time series. The visit 1 of the 
sleep heart health study database (SHHS1, n=2,963, p=24,400) consists of overnight polysomnographic 
(PSG) recordings, and was considered as the test set to evaluate the feasibility of identifying prominent 
AF rhythm from PSG recordings. In SHHS1, expert inspection identified a total of 70 patients with a 
prominent AF rhythm. 
 
Results: Model prediction on the SHHS1 showed an overall 𝑆𝑒 = 0.97, 𝑆𝑝 = 0.99, 𝑁𝑃𝑉 = 0.99,
𝑃𝑃𝑉 = 0.67  in classifying individuals with or without prominent AF. 𝑃𝑃𝑉 was non-inferior (p=0.03) for 
individuals with an apnea-hypopnea index (AHI) ≥ 15 versus AHI < 15. Over 22% of correctly 
identified prominent AF rhythm cases were not documented as AF in the SHHS1. 
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Conclusions: Individuals with prominent AF can be automatically diagnosed from an overnight single 
channel ECG recording, with an accuracy unaffected by the presence of moderate to severe OSA. AF 
detection from overnight single channel ECG recording revealed a large proportion of undiagnosed AF 
and may enhance the phenotyping of OSA by identifying individuals in whom cardiac function may have 
been affected by OSA. 
 
Keywords: digital biomarkers, medicine during sleep, artificial intelligence, atrial fibrillation, obstructive 
sleep apnea. 
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1. Introduction 
Atrial fibrillation 
Atrial fibrillation (AF) is the most common arrhythmia, with a prevalence of 0.95% among the adult 
population 1. It is associated with quivering or irregular heartbeat, that can lead to blood clots, stroke, 
heart failure and other heart-related complications 2. There exist treatments for AF including 
cardioversion and cardiac ablation as well as drugs intending at controlling the heart rate 3. The currently 
accepted convention for AF diagnosis is the presence of an episode lasting at least 30 seconds 3. Many 
individuals with AF go undetected and thus untreated because these are often asymptomatic or have 
paroxysmal AF (PAF) i.e. episodes of AF that occur occasionally. Yet, there are ongoing debates in the 
medical community as per whether mass screening for AF in the general population is to be 
recommended because of the costs involved and uncertainty over the benefits 4. However, there may be 
incentive in performing such systematic screening for specific at high-risk groups 4. 
Value for systematic AF screening during sleep 
We motivate the clinical relevance and feasibility for performing overnight systematic AF screening in 
population sample at risk of sleep disordered breathing5 with three arguments: (1) Interaction of AF with 
sleep disordered breathing: there is incentive in performing systematic AF screening in individuals 
suspected of sleep-disordered breathing. Several pivotal studies conducted over the past decade have 
highlighted a strong association between obstructive sleep apnea (OSA) and AF 6. For example it was 
shown that individuals with severe sleep-disordered breathing have fourfold higher odds of AF than those 
without sleep-disordered breathing after adjustment for potential confounders 7. Given the high 
prevalence of AF1 and OSA8 and the relationship that exists between AF and OSA, there is a high 
motivation for mass AF screening from sleep studies. Yet, to date, very little research has been done 
regarding the analysis of AF during sleep. This is despite the fact that we spend about one third of our 
lives sleeping. (2) Longer recordings: short recordings will lead to missing PAF individuals. In addition, 
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it has been shown that further characterization of the condition over longer intervals, lasting from hours to 
days, may improve phenotyping of the diseases9,10. This motivates performing long continuous 
electrophysiological recording for the purpose of mass AF screening. Performing an overnight recording 
will typically enable to collect 6-7 hours of continuous data.  (3) Diseases expression during sleep: 
previous research has suggested that there exists diurnal variation in the timing of paroxysmal atrial 
fibrillation (PAF) events, with peak incidence at nighttime 11,12. This further motivates leveraging sleep 
recordings for the purpose of AF mass screening. 
Digital health and novelty of the approach taken 
The creation of intelligent algorithms combined with existing and novel wearable biosensors offer an 
unprecedented opportunity to improve the diagnosis and monitoring of patients with AF. We present a 
paradigm per which we intend to use continuous single ECG channel overnight recordings for the purpose 
of mass AF screening in a population at risk of sleep disordered breathing. We present this paradigm as 
novel when comparing with the most recent research attempting at performing mass AF screening from 
video camera 13 or smartwatches pulse recording 14,15. Indeed, video camera usage has the intrinsic 
limitation of being limited in time since the user must hold his finger in front of the phone camera. This 
will lead to numerous undetected PAF cases and the inability to further characterize AF (e.g. by providing 
the AF burden). Smartwatches usage such as in the Apple Heart Study have the advantage of enabling 
longer continuous recordings and analysis. However, in their methodology only intermittent spot 
tachograms were recorded and in the case an irregular pulse was detected, then the algorithm would 
prospectively and opportunistically scan for more irregularity during minimal arm movement. This was 
likely performed to reduce false positives due to noise induced movement in the photoplethysmography 
signal. 
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Working hypothesis 
In this work, we hypothesize that nocturnal AF events can be automatically and accurately identified 
using a machine learning (ML) approach applied to a single channel ECG recording. We further 
hypothesize that the positive predictive value will not be impaired by the presence of OSA. Such proof 
will pave the way to the creation of novel digital health solutions for systematic AF screening in portable 
sleep studies. 
 
2. Methods 
2.1 Databases 
A total of four databases 16,17 totaling n=3,088 patients and p=26,913 hours of data were used.  
Training set databases 
The PhysioNet MIT-BIH Normal Sinus Rhythm (NSR) database: The NSR database 17 is composed of 
n=18 long-term, 21.2 ± 1.2 hours long, electrocardiogram (ECG) recordings, totaling p=384 hours. The 
original ECG measurements were sampled at 128 Hz. The subjects had been referred to the arrhythmia 
laboratory at Boston’s Beth Israel Hospital (BIH) and had no significant arrhythmias apart from the 
presence of ectopic beats. Subjects included 5 men, aged 26-45 years, and 13 women, aged 20-50 years. 
The PhysioNet Long-Term AF (LTAF) database: The LTAF database17 consists of recordings of n=84 
individuals suffering from PAF or sustained AF. Each record contains two simultaneously recorded ECG 
signals digitized at 128 Hz, with 12-bit resolution over a 20 mV range; record durations are of 22.7 ± 2.4 
hours long. The overall database totals p=1,900 hours, including 874 hours in AF and 1,026 hours spent 
in non-AF rhythms. The original recordings were digitized and automatically annotated at Boston’s Beth 
Israel Deaconess Medical Center. R-peak and rhythms annotation were available. These were obtained by 
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manual review of the output of an automated ECG analysis system (PocketECG system, 
MEDICALgorithmics’, Warsaw, Poland). 
Test set databases 
The PhysioNet MIT-BIH AF (BIHAF) database: This database17 includes n=25 long-term ECG recordings 
of human subjects with AF (mostly PAF), totaling p=229 hours of data, with 92 hours in AF and 137 
hours in non-AF rhythms. Of these, 23 records included two ECG channels, sampled at 250 Hz, with 12-
bit resolution, over a range of ±10 millivolts. Two recordings did not have the raw ECG signal available 
and were excluded from the present analysis.  Reference R-peak and rhythms annotation were available. 
The Sleep Heart Health Study (SHHS)  16,18–20 is a multi-center cohort study implemented by the National 
Heart Lung & Blood Institute (ClinicalTrials.gov Identifier: NCT0000527) to determine the 
cardiovascular and other consequences of sleep-disordered breathing. In all, 6,441 men and women aged 
40 years and older were enrolled between November 1, 1995 and January 31, 1998 to take part in SHHS 
Visit 1 (SHHS1). During exam cycle 3 (January 2001-June 2003), a second PSG was performed during 
the SHHS Visit 2 (SHHS2) for 3,295 of the participants.  No distinction was made between AF and atrial 
flutter (AFL) and thus all individuals with documented AF or AFL were labelled “AF”. The original ECG 
used for the purpose of AF diagnosis were obtained from standard resting 12-flead ECG, collected with 
the participant in a supine position, from parent cohorts. ECGs were sampled at 128 Hz and recorded for 
ten seconds for all leads (I, II, III, aVR, aVL, aVF, V1-V6) using a Marquette MAC PC or MAC II 
system. Among participants that had PSG raw data available in SHHS1, n=2,963 had AF labels. 
Summary statistics for age and OSA diagnosis variables are available in Table 1. However, it is not clear 
whether some patients originally diagnosed with AF in one of the parent studies were treated using 
digoxin and/or anti-coagulation (which were the options available at the time of these studies) between 
the time of the 12-lead ECG and the time of the PSG recordings. Thus from an epidemiological 
perspective, by detecting AF in the PSG recordings, we actually seek to identify AF patients whose 
condition manifested as an AF rhythm during SHHS1 and, thus, excluding AF patients that may have 
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been effectively treated. Another important intrinsic limitation is that this diagnosis was based on a 10-
second ECG strip, which might have missed many PAF cases. Conversely, although the Minnesota code 
was used to indicate persistent AF and AFL in the SHHS1 cohort, it is possible that some individuals 
flagged as persistent AF are actually PAF. Such mismatch would be explained by the short recording time 
for diagnosis that would have been performed during an AF event in a patient presenting PAF. 
Recordings re-annotation   
To account for the intrinsic limitation of the labels provided in the SHHS1 database, two intern 
cardiologists (co-author RE and FM) re-examined all 66 ECGs from individuals originally labelled as AF 
as documented in SHHS1. In addition, all recordings predicted with a high AF burden (AFB), defined by 
the percentage of windows predicted as AF, but not originally labelled as AF in the SHHS1, were 
reviewed independently by the two interns. The two interns were asked to classify a recording as AF, 
non-AF or low quality. Within this context, the low quality category was defined as the inability for the 
medical reviewer to make a decision on the presence of AF. In case of disagreement a third senior 
cardiologist (co-author ME), with 25 years of clinical experience, adjudicated. The review was performed 
using the open source software PhysioZoo 21, using a similar setting to that of a traditional Holter review. 
2.2 Data processing 
Signal quality evaluation 
In order to automatically assess the quality of the raw ECG files and discard those that were noisy, we 
included a signal quality preprocessing step. For each 60-beat window, the bsqi index 22 was computed. 
The bsqi index compares the R-peaks detected by two different R-peak detectors: one reference set, 
usually coming from a stronger R-peak detector, and one test set, coming from another, usually weaker R-
peak detector. If the two detectors agree (detect the same beats), then the quality can be assumed to be 
sufficiently high to reliably use the beat-to-beat time series. For the SHHS1, we used the epltd 23 as the 
reference R-peak annotations and xqrs 17 as the test R-peak annotations. We verified that the generated 
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annotations contained at least 1,000 R-peak and excluded files which did not satisfy this criterion i.e. 
corresponding to recordings with a flat ECG. Among the remaining recordings, windows with a bsqi 
lower than 0.8 24 were excluded from the analysis. Recordings showing a rate of exclusion, i.e., the ratio 
between the number of excluded windows and the total number of windows, higher than 75% were 
considered as corrupted and were not considered for analysis. 
HRV-based feature engineering  
A total of nine features, extracted from the statistics of the RR interval time series, were computed for 
each 60-beat window. Five of these features were derived from the work of Lake et al.25 , Sarkar et al.26. 
The other four features were bsqi, signal quality index of the window; AVNN, the mean RR interval 
duration; minRR, the minimal RR interval duration; and medHR, the median heart rate. A reference table 
including the definition of each feature is available in Table 2. 
Machine learning  
To detect AF events, we trained a random forest (RF) model (Supplementary Figure 1). The following 
hyperparameters were optimized using 5-fold cross-validation on the training set databases: the number of 
estimators and the maximal depth of the trees. The selected model included 20 different estimators with 
maximal depth of three. The model was trained on the nine features listed in Table 2. The model then 
returned a label (AF or non-AF) for each 60-beat window. The model was trained on the LTAF and NSR 
databases and tested on the BIHAF database. The hyperparameters of the model being optimized, the 
global model was generated from the three databases (LTAF, NSR and BIHAF) and applied to the 
SHHS1 database. The algorithm was implemented in python using the scikit-learn package. The method 
used to detect AF episodes on these databases is summarized in Figure 1. 
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Classes and performance statistics 
The following statistics were computed: sensitivity (𝑆𝑒), specificity (𝑆𝑝), positive predictive value (𝑃𝑃𝑉), 
area under receiver operating characteristic curve (AUROC) and the harmonic mean between the 𝑆𝑒 and 
𝑃𝑃𝑉, termed the 𝐹1 measure. In the context of the statistics reported for the SHHS1, these parameters are 
defined as: 𝑆𝑒, the percentage of individuals with AF that have been correctly identified as AF out of the 
entire AF population; 𝑆𝑝, the percentage of individuals without AF that have been correctly identified as 
such, out of the whole non-AF population; 𝑃𝑃𝑉, the percentage of individuals correctly identified as 
having AF out of all the individuals that were predicted as AF. We used the statistical non-inferiority test 
recommended in Tuned da Silva et al. 28 to evaluate non-inferiority for a binary endpoint. This test was 
used to demonstrate non-inferiority for the model 𝑃𝑃𝑉 for the OSA versus non-OSA group. Within our 
context we defined population presenting an apnea hypopnea index (AHI) exceeding or equal to 15 as 
OSA and the population presenting an AHI lower than 15 as non-OSA. A tolerance level at 3% was used. 
3. Results  
Signal quality 
Overall, 67 out of 2,963 patients were excluded from the SHHS1 database after the first signal quality 
step (Figure 2). Among the remaining recordings, 10.2% of the windows were excluded by this 
preprocessing step.  
Machine learning model 
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Table 3 displays the results obtained by the model on the training (LTAF, NSR) and test (BIHAF) sets, 
and presents the results of the global model trained on three databases (LTAF, NSR and BIHAF). 
Performance of the RF model on the test set was 𝑆𝑒 = 0.95   and 𝑆𝑝 = 0.98. The ROC curve for the 
global model is presented in Figure 3. The standard deviation in estimating the AFB on the global model 
was 17.6%. We took a conservative threshold at 20%, and classified, for model evaluation on the SHHS1, 
an individual with an estimated AFB≥20% as suffering from prominent AF. Conversely, an individual 
with an estimated AFB <20% was considered as a non-prominent AF patient. This threshold that is close 
to one standard deviation, is used as an estimation of the confidence on the algorithm performance in 
estimating the AFB. Taking a threshold that is low would results in a significant number of FP and impair 
the merit of this approach. 
Re-annotation of SHHS1 AF labels 
Out of 118 reannotated recordings (66 originally labeled as AF and 52 predicted positive by the RF 
model), annotator A and B agreed on 106. Among these there were a total of 65 AF cases, 39 non-AF 
cases and 2 cases labeled as low quality. The two low quality recordings were excluded. For the 
remaining 12 recordings where the two annotators disagreed, annotator A identified 9 AF, 3 non-AF and 
annotator B identified 3 cases as AF, 7 as non-AF and 2 as low quality. Adjudication on the 12 cases was 
performed by a senior cardiologist. Out of 12 cases, 5 were adjudicated as AF and 3 as non-AF. The 
remaining 4 recordings were too noisy for the senior cardiologist to provide a decision. These were 
removed from the analysis. The final labels for the annotated recordings consisted of 70 cases of AF, 42 
cases of non-AF and 6 excluded files. A summary diagram is provided in Figure 2. 
Performance evaluation on the SHHS1 
Table 4  summarizes the statistics obtained on the SHHS1 for the detection of prominent AF, for both 
OSA (AHI≥15) and the non-OSA (AHI<15) groups based on the re-annotated labels. 103 patients (3.5%) 
were identified with prominent AF. The median (Q1-Q3) age for the prominent versus non-prominent AF 
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groups were 77 (74.5-80) and 67 (53-76) years respectively (p<0.05). There were a total of 64 males 
(62%) in the prominent AF group against 1241 (44.5%) in the non-prominent group (p<0.05). The overall 
classification performance was 𝑆𝑒 = 0.97,   and 𝑆𝑝 = 0.99. For non-OSA individuals, the classification 
performance was 𝑆𝑒 = 0.96  and  𝑆𝑝 = 0.99. For individuals with OSA, the classification performance 
was 𝑆𝑒 = 0.98 and 𝑆𝑝 = 0.99. Non-inferiority testing for the model 𝑃𝑃𝑉 for the OSA versus non-OSA 
group was demonstrated (p=0.03). Figure 4 shows the distribution of the estimated AFB among 
prominent AF and non-prominent AF populations constituting the SHHS1 database, using the re-
annotated labels.  
3. Discussion 
Signal quality 
A total of 10.2% of the windows were removed by the signal quality step (𝑏𝑠𝑞𝑖 < 0.8). This rather high 
number may be attributable to the poor quality of the signal towards the end of the recordings, when the 
electrodes are removed, once the patient wakes up, but before the ECG monitor has been switched off by 
the nurse or the technician. In fact, exclusion of the last 10% of the recordings would reduce window 
removal to 7.7% (versus 10.2%). In addition, ECG electrodes are often placed in sleep laboratories with 
less care as compared to Holters or in-hospital 12-lead ECG electrodes, because the ECG is considered to 
be an auxiliary signal in PSG analysis and not as the primary signal of interest. This further explains the 
rather large number of windows discarded. 
Error analysis 
After re-annotation, 70 patients were identified as suffering from prominent AF. This represents 2.4% of 
our population sample. A total of 103 patients were predicted by the RF model to have an AFB exceeding 
20%. Two cases of AF were false negatives (FN) i.e. missed by the RF model. In total, there were 35 
false positives (FP), i.e., cases inaccurately predicted as prominent AF. This is summarized in Figure 2. 
Among the FN, one individual presented a highly regular and slow rhythm (40 bpm in average) and was 
diagnosed as AFL by the intern cardiologists (Figure 5A). The second FN case was classified by the 
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intern cardiologists as PAF. This individual had an estimated AFB of 15% and visual inspection of the 
windows identified as AF showed that the RF model behavior was accurate (Figure 5B). Thus, this FN 
resulted from an intrinsic design limitation relating to the 20% decision threshold separating between 
prominent and non-prominent AF. The false positives (FP) of our model were all due to highly irregular 
RR interval time series which misled the RF model. Among the 35 FP problematic cases, 14 cases 
presented a sinus rhythm with high variability (e.g., Figure 6A), 18 presented a sinus rhythm with 
different forms of ectopic beats (atrial premature complexes and premature ventricular contractions, e.g., 
Figure 6B), and 3 were diagnosed with other kinds of rhythm (cardiac rhythm exerted by a pacemaker, 
trigeminy, bigeminy, e.g. Figure 6C).  
Feasibility of diagnosing AF from PSG recordings 
Opportunistic detection of AF using a single and short ECG measurement will miss asymptomatic cases 
and PAF individuals who are in sinus rhythm during the time of the measurement 4,29. In this respect, 
overnight continuous recording and ML driven analysis represents an opportunity to tackle these 
limitations. In this research, a total of 16 individuals with no documented diagnosis of AF and 
representing over 22% (16/70) of individuals with prominent AF, were identified by the RF model. These 
16 patients had a significantly lower (p<0.05, Figure 7) estimated AF burden than the 54 individuals 
already documented as AF in SHHS1 and confirmed by the intern cardiologists. This stresses that 
individuals with a lower AF burden are more likely to be undiagnosed and that our approach may identify 
them. In addition, among the 16 newly identified AF cases, 8 participated in the SHHS2. Among these 8 
patients, 4 were documented as AF in SHHS2 and 3 as non-AF. This further strengthen the value of 
leveraging sleep recordings for the purpose of prominent AF diagnosis. 
Interaction with OSA 
Accurate evaluation of the AFB may enhance phenotyping of OSA, by enabling the identification of 
individuals whose OSA condition may have already affected cardiac function. Identification of AF was 
not affected by the presence of OSA. The SHHS1 analysis showed non-inferior PPV for the OSA group 
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compared to the non-OSA group, with OSA defined as AHI≥15 (p=0.03). Among the individuals with 
prominent AF, 36% (25/70) had an AHI<15 and 64% (45/70) had an AHI≥15. This corresponds to 1.6% 
of the population with AHI<15 and 3.6% of the population with AHI≥15. Thus, individuals with 
moderate to severe OSA had significantly (p=0.0004) higher prevalence of AF than the group with 
AHI<15, which is in accordance with previous studies. 
Newly identified prominent AF cases and strokes 
Among the 16 patients correctly diagnosed with AF and with no previous AF diagnosis documented in 
the SHHS1, 4 (25%) later had at least one stroke (Table 5). The stroke was fatal for one of these cases 
(25%). Among these 4 patients, 3 had persistent AF rhythm and 1 had paroxysmal AF rhythm. Three 
patients had mild OSA (𝐴𝐻𝐼 > 5) and one severe OSA (𝐴𝐻𝐼 > 30). In comparison, among the AF cases 
that were documented in the SHHS1, 13 (19.7%) had at least one stroke. The stroke was fatal in 3 of these 
cases (23%). Whether the relationship between the phenotype OSA plus AF and stroke is causal or simply 
associative, these results further highlight the importance in robustly identifying patients with AF in PSG 
recordings. 
Medicine during sleep: a new perspective 
Today, many digital health home sleep test with portable sensors, have been developed and are already in 
extensive use for diagnosing sleep disorder breathing. Data-driven algorithms have shown good results at 
performing automated analysis 30. This shift to portable digital health monitoring technology has 
effectively addressed the growing awareness of the number of individuals with sleep disorders. The PSG 
should be reserved for complicated OSA phenotypes, such as the overlap syndrome between OSA and 
chronic obstructive pulmonary disease, patients with heart failure or more complicated sleep conditions. 
These cases should be referred to sleep specialists, whereas obvious cases should be analyzed by other 
medical professionals, such as general practitioners. Yet, the data collected with PSG or home sleep tests 
gather valuable physiological measurements that extend beyond the pure traditional sleep diagnosis 
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paradigm. We highlight in this paper the diagnostic potential of data collected during sleep for non-sleep 
specific conditions, a paradigm we coined earlier as “medicine during sleep” 5. Although such novel 
analysis of the data may be fully automated in the distant future, it is likely, in the near future, that the 
data and its automated analysis will be presented to a medical doctor for review. We thus foresee, a new 
area of engineering research dedicated to the analysis of data collected during sleep for the purpose of 
non-sleep-specific diagnosis and monitoring. This also paves the way for a new generation of sleep 
medical doctors whose training will include a familiarity with the analysis of such data recorded during 
sleep for diagnosis of non-sleep-specific conditions. To this end, we demonstrated the feasibility of 
identifying patients with prominent AF from overnight single channel ECG recording. 
 
Limitations 
A critical limitation of this work was the underlying assumption that a data-driven approach to AF 
detection can detect patterns in the RR interval time series analysis which are specific to AF. This might 
be limiting because the model may misclassify patients as AF because they exert a highly irregular RR 
time series due to other cardiovascular pathologies. This might be an intrinsic limitation of the approach 
or the expression of a lack of sufficient recordings of cardiac conditions, other than AF, characterized by 
a highly irregular RR. This is true in particular for patients presenting a high number of ectopic beats. 
Increasing the representation of such cases in the training process or adding additional discriminative 
features 31 might improve the ability of the model to learn to distinguish these cases from AF.  
A second key limitation was that only some and not all of the recordings in the SHHS1 were reannotated 
by a medical expert, due to the substantial time it would take for the medical expert to re-annotate all the 
2,963 files with a total of 24,400 hours of ECG. Each medical expert spent, on average, 30 minutes 
reviewing a single overnight ECG recording. Consequently, we may have missed AF cases with no 
history of AF (as provided by the SHHS1 labels on AF) and with no prediction of a high AF burden. This 
limitation may be particularly important for the AFL cases which would not manifest with an irregular 
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RR such as the one case documented in Figure 5A and which was one of the two FN of the RF model. It 
is also important to note that only a single channel ECG was available from the PSG recordings which is 
less than in the more traditional 3 or 12-lead Holter ECG used in a classical medical Holter review 
process. This made the intern cardiologist review process more challenging in distinguishing between 
noisy sinus waves and fibrillation waves as well as did not enable to confirm the arrhythmias from 
multiple channels views.  
The last main limitation of this study was the AF burden threshold at 20%, used to distinguish between 
prominent AF and non-prominent AF. This threshold was motivated by the intrinsic capacity of the data-
driven algorithm developed and evaluated on the PhysioNet databases, to correctly estimate the AF 
burden of a patient. Indeed, given the current ability of the RF model, using a smaller threshold would 
result in many false positives and thus, to too many false alarms for the clinical staff to review. However, 
training on a larger dataset and with improved features will improve the AF burden estimation and enable 
lowering the decision threshold on SHHS1. 
Conclusion 
Several pivotal studies conducted over the past decade have highlighted a strong association between 
obstructive sleep apnea (OSA) and atrial fibrillation (AF). Given the high prevalence of both conditions 
and their association, there is a high motivation to automatically identify individuals presenting AF in 
sleep studies in order to better phenotype OSA. We show that individuals with prominent AF can be 
automatically diagnosed from an overnight single channel ECG recording using digital biomarkers and 
artificial intelligence and with PPV unaffected by the presence of moderate to severe OSA. This paves the 
way to novel digital health solution for systematic AF screening in portable sleep studies. We further 
show that AF detection enabled to identify previously undiagnosed AF cases with over 22% of all AF 
cases that were previously non-documented. These cases were likely missed by the previous, short AF 
diagnosis test, but could now be identified by the automated overnight test. 
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List of figures 
 
Figure 1.  Perspective and summary methods of this research. The clinical perspective:  systematic 
screening individuals suspected of sleep-disordered breathing where an important association between AF 
and obstructive sleep apnea (OSA) has been demonstrated. Summary methods: (1) training databases 
(LTAF, BIHAF and NSR) are used to train a machine learning (ML) model in recognizing AF events 
from the beat-to-beat interval time series; (2) the trained model is applied to an independent database of 
polysomnography recordings (SHHS1) to demonstrate how the classifier generalizes to this independent 
sleep database and enables to automatically recognize individuals with prominent AF in both non-OSA 
and OSA individuals. 
23 
 
 
Figure 2. Data exclusion process and summary of the per-patient classification results. After the 
exclusion steps, 2,890 files were considered. Among these, 2,787 were diagnosed with an AF burden 
(AFB) below 20%, and 103 were diagnosed with an AFB exceeding 20% and hence classified as 
24 
 
prominent AF. There were 2 false negative cases with AF missed by the RF model, and 35 false positives 
flagged as AF despite absence of the condition.   
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Figure 3. ROC curves of the Random Forest classifier compared to two benchmark features widely used 
in the field of AF detection: the coefficient of Sample Entropy (cosEn, in red), and AFEvidence (AFEv, in 
blue). This ROC curve is represented for the global model. 
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Figure 4. Normalized histograms of atrial fibrillation (AF) burden (x-axis) as predicted by the RF model 
for prominent AF individuals (𝐴𝐹𝐵 ≥ 20%), determined after the reannotation. The vertical dotted line 
illustrates the decision threshold used to separate between prominent and non-prominent AF. 
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Figure 5. ECG recordings and corresponding RR intervals of the two patients missed by the RF model. 
Panel a: the recording of patient number 202505, diagnosed by the cardiologist as slow atrial flutter 
(AFL), and missed by the RF model because of his highly regular RR interval. Panel b, the recording of 
patient number 202845, diagnosed with paroxysmal atrial fibrillation (AF), whose AF events were 
correctly flagged by the RF model, but presented an AF burden below the threshold (20%) and hence was 
not flagged as prominent AF. 
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Figure 6. ECG recordings of several patients incorrectly classified as AF patients. (a), the recording of 
patient number 202599 which showed an irregular sinus rhythm; (b), the recording of patient number 
202564 which presents a sinus rhythm with atrial premature complexes; (c), recording of patient number 
201290 presenting a trigeminy; (d) shows the recording of patient number 201603 which included a noisy 
RR interval and which could not be classified by the cardiologist. 
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Figure 7: Boxplot of the atrial fibrillation burden (AFB) for the individuals already documented in 
SHHS1 as AF and confirmed by the intern cardiologist and for the cases predicted by our model and 
confirmed by the intern cardiologist as AF. 
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Tables 
Table 1. Description of the SHHS1 database for whom AF labels were available (n=2,963). AHI: apnea 
hypopnea index, ODI: oxygen desaturation index, BMI: body mass index. 
 Age AHI ODI BMI 
Median 69 13.23 5.81 27.25 
Q1 53 6.53 3.38 24.55 
Q3 76 23.56 10.37 30.41 
Min 39 0.0 0.0 18.0 
Max 90 161.84 78.06 50.0 
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Table 2. List of the features extracted from the RR time-series windows and used within the RF model to 
distinguish AF events. 
Features Definition 
bSQI Signal quality of the window 24 
CosEn Coefficient of sample entropy 25 
AFE AFEvidence 26 
OrC Number of points in the bin containing the Origin 26 
IrE Irregularity Evidence 26 
PACe PAC Evidence 26 
AVNN Average NN interval duration 
minRR Minimum RR interval 
medHR Median heart rate  
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Table 3. Performance of the model on the training (NSR, LTAF) and test (BIHAF) sets as well as of the 
global model (NSR, LTAF and BIHAF). 
 Training Test Global Model 
Se 0.97 
(75643/78251) 
0.95 
(8077/8470) 
0.97 
(83780/86721) 
Sp 0.87 
(89028/102739) 
0.98 
(10139/10327) 
0.87 
(99164/113066) 
PPV 0.85 
(75643/89423) 
0.98 
(8077/8265) 
0.86 
(83780/97682) 
NPV 0.97 
(88959/91567) 
0.96 
(10139/10532) 
0.97 
(99164/102105) 
AUROC 0.96 0.99 0.96 
F1 0.90 0.97 0.91 
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Table 4. Performance of the model in detecting AF individuals in the SHHS1 database after reannotations 
of all recordings predicted with 𝐴𝐹 𝑏𝑢𝑟𝑑𝑒𝑛 ≥  0.2 and review of the positive AF labels previously 
documented in the SHHS1. 
 All 𝑨𝑯𝑰 < 𝟏𝟓 𝑨𝑯𝑰 ≥ 𝟏𝟓 
Se 0.97 
(68/70) 
0.96 
(24/25) 
0.98 
(44/45) 
Sp 0.99 
(2785/2820) 
0.99 
(1561/1579) 
0.99 
(1224/1241) 
PPV 0.66 
(68/103) 
0.57 
(24/42) 
0.75 
(44/61) 
NPV 0.99 
(2785/2787) 
0.99 
(1561/1562) 
0.99 
(1224/1225) 
AUROC 0.99 0.99 0.99 
𝐹1 0.79 0.72 0.83 
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Table 5: Summary statistics for newly identified prominent AF individuals who later had one or more 
strokes. 
ID 
Number 
of strokes 
Fatal 
AF Burden 
(%) 
 Time to 
stroke 
(years) 
AHI 
(events/hour) 
ODI 
(events/hour) 
Age 
(years) 
202371 1 No 100 0.93 60.4 49.78 77 
204095 2 No 100 1.86 7.5 4.05 80 
202004 2 Yes 56 6.19 10.8 4.25 79 
202462 1 No 29 2.64 7.65 5.28 82 
Median 
(Q1-Q3)   
77.6 
(48.9-99.8) 
2.25 
(1.62-3.52) 
7.7 
(7.6-23.1) 
4.76 
(4.20-16.40) 
79 
(78.5-80) 
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Supplement 
 
 
Supplementary Figure 1. Illustration of the Random Forest (RF) model used to classify the events as AF 
or non-AF. The model is fed with a subset of examples containing each nine features derived from beat-
to-beat time series. The model decision is based on a subset of decision trees with a given maximal depth 
(here, maximal depth of 2). Each tree is trained based on a subset of the original training set drawn with 
replacement. Eventually, the model classifies a given example based on the majority vote among the 
trees.  
 
 
 
